Dysregulation of this signaling can lead to metabolic disorders such as diabetes, obesity, and insulin resistance syndromes.176 Understanding the details of insulin/IGF signaling pathways and their interactions is crucial for developing effective therapeutic interventions for these conditions. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.